Requirement for myd88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in lyn-deficient mice

Journal of Immunology

Volumn 192, Issue 3, 2014, Pages 875-885

  Hua, Zhaolin ^a   Gross, Andrew J ^b   Lamagna, Chrystelle ^b   Ramos Hernández, Natalia ^b   Scapini, Patrizia ^b,c   Ji, Ming ^b   Shao, Haitao ^a   Lowell, Clifford A ^b   Hou, Baidong ^a,b   DeFranco, Anthony L ^b  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE LYN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; GENE DELETION; GERMINAL CENTER; GLOMERULONEPHRITIS; IMMUNOGLOBULIN DEPOSITION; MOUSE; MYD88 GENE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; B-LYMPHOCYTES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GENE DELETION; GERMINAL CENTER; HUMANS; IMMUNOGLOBULIN G; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOCYTE COUNT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SELF TOLERANCE; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; SRC-FAMILY KINASES; TOLL-LIKE RECEPTORS;

EID: 84893364183     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300683     Document Type: Article

References (56)

1. Rahman, A., and D. A. Isenberg. 2008. Systemic lupus erythematosus. N. Engl. J. Med. 358: 929-939.
2. Pathak, S., and C. Mohan. 2011. Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. Arthritis Res. Ther. 13: 241.
3. Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker, and A. R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83: 301-311.
4. Xu, Y., K. W. Harder, N. D. Huntington, M. L. Hibbs, and D. M. Tarlinton. 2005. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22: 9-18.
5. Scapini, P., S. Pereira, H. Zhang, and C. A. Lowell. 2009. Multiple roles of Lyn kinase in myeloid cell signaling and function. Immunol. Rev. 228: 23-40.
6. Smith, K. G., D. M. Tarlinton, G. M. Doody, M. L. Hibbs, and D. T. Fearon. 1998. Inhibition of the B cell by CD22: a requirement for Lyn. J. Exp. Med. 187: 807-811.
7. Chan, V. W., C. A. Lowell, and A. L. DeFranco. 1998. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr. Biol. 8: 545-553.
8. Scapini, P., Y. Hu, C. L. Chu, T. S. Migone, A. L. Defranco, M. A. Cassatella, and C. A. Lowell. 2010. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J. Exp. Med. 207: 1757-1773.
9. Scapini, P., C. Lamagna, Y. Hu, K. Lee, Q. Tang, A. L. DeFranco, and C. A. Lowell. 2011. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc. Natl. Acad. Sci. USA 108: E823-E832.
10. Krebs, D. L., M. K. Chehal, A. Sio, N. D. Huntington, M. L. Da, P. Ziltener, M. Inglese, N. Kountouri, J. J. Priatel, J. Jones, et al. 2012. Lyn-dependent signaling regulates the innate immune response by controlling dendritic cell activation of NK cells. J. Immunol. 188: 5094-5105.
11. Lamagna, C., P. Scapini, J. A. van Ziffle, A. L. DeFranco, and C. A. Lowell. 2013. Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation. Proc. Natl. Acad. Sci. USA 110: E3311-E3320.
12. Lu, R., G. S. Vidal, J. A. Kelly, A. M. Delgado-Vega, X. K. Howard S. R. Macwana, N. Dominguez, W. Klein, C. Burrell, I. T. Harley, et al; BIOLUPUS and GENLES Multicenter Collaborations. 2009. Genetic associations of LYN with systemic lupus erythematosus. Genes Immun. 10: 397-403.
13. Surolia, I., S. P. Pirnie, V. Chellappa, K. N. Taylor, A. Cariappa, J. Moya, H. Liu, D. W. Bell, D. R. Driscoll, S. Diederichs, et al. 2010. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature 466: 243-247.
14. Tsantikos, E., M. J. Maxwell, N. Kountouri, K. W. Harder, D. M. Tarlinton, and M. L. Hibbs. 2012. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development. J. Immunol. 189: 1726-1736.
15. Green, N. M., and A. Marshak-Rothstein. 2011. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin. Immunol. 23: 106-112.
16. Nickerson, K. M., S. R. Christensen, J. Shupe, M. Kashgarian, D. Kim, K. Elkon, and M. J. Shlomchik. 2010. TLR9 regulates TLR7-And MyD88-dependent autoantibody production and disease in a murine model of lupus. J. Immunol. 184: 1840-1848.
17. Silver, K. L., T. L. Crockford, T. Bouriez-Jones, S. Milling, T. Lambe, and R. J. Cornall. 2007. MyD88-dependent autoimmune disease in Lyn-deficient mice. Eur. J. Immunol. 37: 2734-2743.
18. Pisitkun, P., J. A. Deane, M. J. Difilippantonio, T. Tarasenko, A. B. Satterthwaite, and S. Bolland. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312: 1669-1672.
19. Subramanian, S., K. Tus, Q.-Z. Li, A. Wang, X.-H. Tian, J. Zhou, C. Liang, G. Bartov, L. D. McDaniel, X. J. Zhou, et al. 2006. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103: 9970-9975.
20. Ehlers, M., H. Fukuyama, T. L. McGaha, A. Aderem, and J. V. Ravetch. 2006. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 203: 553-561.
21. Herlands, R. A., S. R. Christensen, R. A. Sweet, U. Hershberg, and M. J. Shlomchik. 2008. T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity 29: 249-260.
22. Gilliet, M., W. Cao, and Y. J. Liu. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8: 594-606.
23. Banchereau, J., and V. Pascual. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383-392.
24. Hou, B., P. Saudan, G. Ott, M. L. Wheeler, M. Ji, L. Kuzmich, L. M. Lee, R. L. Coffman, M. F. Bachmann, and A. L. DeFranco. 2011. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity 34: 375-384.
25. Hou, B., B. Reizis, and A. L. DeFranco. 2008. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity 29: 272-282.
26. Caton, M. L., M. R. Smith-Raska, and B. Reizis. 2007. Notch-RBP-J signaling controls the homeostasis of CD82 dendritic cells in the spleen. J. Exp. Med. 204: 1653-1664.
27. Hobeika, E., S. Thiemann, B. Storch, H. Jumaa, P. J. Nielsen, R. Pelanda, and M. Reth. 2006. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA 103: 13789-13794.
28. Czar, M. J., E. N. Kersh, L. A. Mijares, G. Lanier, J. Lewis, G. Yap, A. Chen, A. Sher, C. S. Duckett, R. Ahmed, and P. L. Schwartzberg. 2001. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc. Natl. Acad. Sci. USA 98: 7449-7454.
29. Itohara, S., P. Mombaerts, J. Lafaille, J. Iacomini, A. Nelson, A. R. Clarke, M. L. Hooper, A. Farr, and S. Tonegawa. 1993. T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell 72: 337-348.
30. Mombaerts, P., A. R. Clarke, M. L. Hooper, and S. Tonegawa. 1991. Creation of a large genomic deletion at the T-cell antigen receptor beta-subunit locus in mouse embryonic stem cells by gene targeting. Proc. Natl. Acad. Sci. USA 88: 3084-3087.
31. Yu, C. C., T. S. Yen, C. A. Lowell, and A. L. DeFranco. 2001. Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr. Biol. 11: 34-38.
32. Radic, M. Z., and M. Weigert. 1994. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 12: 487-520.
33. William, J., C. Euler, S. R. Christensen, and M. J. Shlomchik. 2002. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297: 2066-2070.
34. Groom, J. R., C. A. Fletcher, S. N. Walters, S. T. Grey, S. V. Watt, M. J. Sweet, M. J. Smyth, C. R. Mackay, and F. Mackay. 2007. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J. Exp. Med. 204: 1959-1971.
35. Crotty, S., E. N. Kersh, J. Cannons, P. L. Schwartzberg, and R. Ahmed. 2003. SAP is required for generating long-term humoral immunity. Nature 421: 282-287.
36. Cannons, J. L., S. G. Tangye, and P. L. Schwartzberg. 2011. SLAM family receptors and SAP adaptors in immunity. Annu. Rev. Immunol. 29: 665-705.
37. Tsantikos, E., C. Quilici, K. W. Harder, B. Wang, H. J. Zhu, G. P. Anderson, D. M. Tarlinton, and M. L. Hibbs. 2009. Perturbation of the CD4 T cell compartment and expansion of regulatory T cells in autoimmune-prone Lyn-deficient mice. J. Immunol. 183: 2484-2494.
38. Gutierrez, T., J. M. Mayeux, S. B. Ortega, N. J. Karandikar, Q. Z. Li, D. Rakheja, X. J. Zhou, and A. B. Satterthwaite. 2013. IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/-mice. Eur. J. Immunol. 43: 382-393.
39. Coffman, R. L., A. Sher, and R. A. Seder. 2010. Vaccine adjuvants: putting innate immunity to work. Immunity 33: 492-503.
40. Tsantikos, E., S. A. Oracki, C. Quilici, G. P. Anderson, D. M. Tarlinton, and M. L. Hibbs. 2010. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6. J. Immunol. 184: 1348-1360.
41. Gross, A. J., I. Proekt, and A. L. DeFranco. 2011. Elevated BCR signaling and decreased survival of Lyn-deficient transitional and follicular B cells. Eur. J. Immunol. 41: 3645-3655.
42. Shahaf, G., A. J. Gross, M. Sternberg-Simon, D. Kaplan, A. L. DeFranco, and R. Mehr. 2012. Lyn deficiency affects B-cell maturation as well as survival. Eur. J. Immunol. 42: 511-521.
43. Meade, J., C. Fernandez, and M. Turner. 2002. The tyrosine kinase Lyn is required for B cell development beyond the T1 stage in the spleen: rescue by overexpression of Bcl-2. Eur. J. Immunol. 32: 1029-1034.
44. Merrell, K. T., R. J. Benschop, S. B. Gauld, K. Aviszus, D. Decote-Ricardo, L. J. Wysocki, and J. C. Cambier. 2006. Identification of anergic B cells within a wild-type repertoire. Immunity 25: 953-962.
45. Hwang, S. H., H. Lee, M. Yamamoto, L. A. Jones, J. Dayalan, R. Hopkins, X. J. Zhou, F. Yarovinsky, J. E. Connolly, M. A. Curotto de Lafaille, et al. 2012. B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice. J. Immunol. 189: 5786-5796.
46. Walsh, E. R., P. Pisitkun, E. Voynova, J. A. Deane, B. L. Scott, R. R. Caspi, and S. Bolland. 2012. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proc. Natl. Acad. Sci. USA 109: 16276-16281.
47. Rawlings, D. J., M. A. Schwartz, S. W. Jackson, and A. Meyer-Bahlburg. 2012. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat. Rev. Immunol. 12: 282-294.
48. Oracki, S. A., E. Tsantikos, C. Quilici, A. Light, T. Schmidt, A. M. Lew, J. E. Martin, K. G. Smith, M. L. Hibbs, and D. M. Tarlinton. 2010. CTLA4Ig alters the course of autoimmune disease development in Lyn-/-mice. J. Immunol. 184: 757-763.
49. Wofsy, D. 1993. Treatment of murine lupus with anti-CD4 monoclonal antibodies. Immunol. Ser. 59: 221-236.
50. Shlomchik, M. J. 2009. Activating systemic autoimmunity: B's, T's, and tolls. Curr. Opin. Immunol. 21: 626-633
51. Cline, A. M., and M. Z. Radic. 2004. Murine lupus autoantibodies identify distinct subsets of apoptotic bodies. Autoimmunity 37: 85-93.
52. Pao, L. I., K. P. Lam, J. M. Henderson, J. L. Kutok, M. Alimzhanov, L. Nitschke, M. L. Thomas, B. G. Neel, and K. Rajewsky. 2007. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27: 35-48.
53. Jellusova, J., U. Wellmann, K. Amann, T. H. Winkler, and L. Nitschke. 2010. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. J. Immunol. 184: 3618-3627.
54. Hermiston, M. L., A. L. Tan, V. A. Gupta, R. Majeti, and A. Weiss. 2005. The juxtamembrane wedge negatively regulates CD45 function in B cells. Immunity 23: 635-647.
55. Zikherman, J., R. Parameswaran, M. Hermiston, and A.Weiss. 2013. The structural wedge domain of the receptor-like tyrosine phosphatase CD45 enforces B cell tolerance by regulating substrate specificity. J. Immunol. 190: 2527-2535.
56. Gross, A. J., J. R. Lyandres, A. K. Panigrahi, E. T. Prak, and A. L. DeFranco. 2009. Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance. J. Immunol. 182: 5382-5392.